Health Canada joins Nov. 2–8 campaign urging reports of suspected side effects
In this article & details
Health Canada is joining the World Health Organization’s annual #MedSafetyWeek campaign from November 2 to 8, 2026. This year’s message is “Side effects – don’t ignore them, report them.” The department announced the Canadian participation in its October 29 Health Product InfoWatch update, which also directs people to the Canada Vigilance reporting program.
The campaign highlights a basic challenge in medicine safety: pre-market studies cannot reveal every possible reaction. Trials typically involve selected groups and limited follow-up. Once a health product is used more widely and for longer, uncommon or delayed problems may become more visible. Health Canada says reports from patients and health professionals contribute to its ongoing post-market monitoring.
Reports are signals, not proof of cause
A suspected reaction should not be presented as confirmed harm from a particular medicine simply because it was reported. Health Canada explains that each case must be assessed on its own, and that more than one report is usually needed to identify a potential signal. A signal is an early indication for review—not proof of a causal connection. Regulators may investigate further and, when warranted, change product information or take other regulatory action.
That distinction matters in pharmacy conversations. Reporting gives regulators information to assess patterns across products and patients; it does not replace clinical assessment of an individual event. A patient who is experiencing a serious or urgent reaction should seek prompt medical care. For questions about whether to continue, pause or change a treatment, they should speak with their prescriber or pharmacist rather than rely on a campaign message or a single report.
Who can report, and what is covered?
Health Canada accepts reports from anyone, including patients, caregivers and health professionals. The reporting system covers suspected side effects or problems involving prescription and non-prescription drugs, biologics, vaccines, medical devices and natural health products, among other product types. People do not need to be certain that a product caused the event before submitting a report; the department asks that suspected problems be reported even when the connection is unclear.
For pharmacy teams, the week is a timely prompt to know where the official reporting form is, how to direct a patient who wants to report, and how to distinguish external adverse-reaction reporting from the pharmacy’s own incident documentation and any local reporting requirements. The campaign itself does not announce a new recall, a new product warning or a change to pharmacists’ legal duties.
Health Canada’s online reporting page explains how to submit a report. The Canada Vigilance Program can use reports to help detect rare or serious reactions and to inform later safety communications. Reporting therefore supports population-level monitoring, while individual diagnosis and treatment decisions remain a separate clinical process.
